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This study examines the current practices within South Eastern Sydney 
Illawarra Area Health Service (SESIAHS) in relation to the screening of 
pregnant women for gestational diabetes mellitus (GDM). It is hoped that 
by examining the current practices and determining what would be 
considered best practice for screening for GDM, the research will form the 
platform for the development of Area wide practice guidelines. 
Why study GDM? In 2004 in my workplace, which is a rural maternity unit 
in New South Wales (NSW), two near term stillbirths occurred in quick 
succession. Both were babies born to women who had poorly controlled 
GDM. A period of reflection ensued which prompted me to undertake this 
research. The starting point of this quest was a review of local practices 
relating to the screening, diagnosis and management of GDM. Following 
this, a review of the literature revealed a lack of consensus, not just on a 
local level, but on a global scale. 
The questions generated by the clinical events and initial investigations 
required refinement to a focussed researchable question, which could 
impact on clinical practice to improve outcomes for mothers and babies. 
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Aim:  The aim was to examine the current practices related to the screening 
and diagnosis of Gestational Diabetes Mellitus (GDM) in the South Eastern 
Sydney Illawarra Area Health Service (SESIAHS), and to provide evidence 
to form the basis for the development of appropriate evidence-based 
guidelines for screening for GDM in this Area Health Service. 
The objectives of the study were to: 
1) Identify the range of practices employed for the screening and diagnosis 
for GDM across the SESIAHS; 
2) Assess the level of screening by oral glucose challenge test (OGCT) and 
adherence to site policies regarding this test; and, 
3) Establish the incidence of GDM in women giving birth at the three sites 
within the SESIAHS. 
Study Design: A retrospective, quantitative, descriptive study, with 
comparative analysis of data between sites was undertaken. The aims and 
objectives of the study were addressed through examination of the policies 
and guidelines at the three sites and an assessment of the level of screening 
by oral glucose challenge test (OGCT). This was achieved through a 
medical record audit which also identified adherence to site policies 
regarding screening. The incidence of GDM in women giving birth at the 
three locations was ascertained via the Midwives Data Collection. 
Comparison of site and population characteristics was undertaken to 
explore any differences between the facilities. 
Sample: Three components formed the sample for the study. These 
included the policies and guidelines from the three sites to identify the 
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range of practices employed to screen for GDM. The second sample 
component was 90 to 100 medical records per site for audit purposes to 
assess the level of screening by OGCT and adherence to site policies. The 
final component of the sample consisted of all women who gave birth at 
three sites in the SESIAHS from 2001 to 2005.  
Results: There was a lack of consensus surrounding GDM apparent within 
the South Eastern Sydney Illawarra Area Health Service. Three differing 
approaches to screening for GDM were identified on examination of site 
policies and guidelines. Screening of women for GDM by OGCT or the 
one step diagnostic OGTT ranged from 76 – 88% at the three sites. Non-
adherence to site policies was present in 11 – 14% of records examined. 
Risk factors for GDM were readily identified in 61 – 91% of the women 
whose medical records were reviewed. Over the five year study period, the 
incidence of GDM at Site 1 was 3.0 – 5.1%; at Site 2 it was 4.1 – 5.9%, and 
at Site 3 it was 5.5 – 7.1%. The incidence of GDM in the entire SESIAHS 
was 3.7 – 4.3% and in NSW 3.8 – 4.7% during the study period.  
Conclusions: A universal screening strategy which offers the OGCT to all 
women is recommended. This conclusion has been reached after 
consideration of the findings of the literature review, the upward trend of 
GDM, and the high rate of GDM risk factors identified in the women at the 
three sites within the SESIAHS. Added to these features, the omission of 
screening for GDM in 11 – 14% of women with risk factors further 
supports a universal screening strategy. This strategy would serve to 
remove confusion around whether or not to offer a screening test to 
pregnant women. A uniform approach, based on the best available 
evidence, should be developed to guide screening, diagnosis and treatment 
practices for GDM within the SESIAHS. 
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